期刊文献+

非酒精性脂肪肝肝纤维化评分与脂肪肝及胰岛素抵抗的相关性研究 被引量:5

Relationship of nonalcoholic fatty liver disease fibrosis score with fatty liver disease and insulin resistance
原文传递
导出
摘要 目的分析非酒精性脂肪肝肝纤维化评分(NAFLDFS)与非酒精性脂肪肝(NAFLD)及胰岛素抵抗(IR)的相关性。方法以来自江苏徐州地区的2622例健康体检人群为研究对象,检测受试者的血清谷丙转氨酶(ALT),谷草转氨酶(AST),血小板计数(PLT),血清白蛋白(ALB),空腹血糖(FBG),餐后2 h血糖(PBG),空腹胰岛素(Fins)等相关生化指标,计算出NAFLDFS及胰岛素抵抗指数(HOMA2-IR),将研究对象按非酒精性脂肪肝纤维化评分的低诊断阈值(-1.455)及高诊断阈值(0.676)分成三组,A1组:NAFLDFS<-1.455;A2组:0.676≥NAFLDFS≥-1.455和A3组NAFLDFS>0.676。Pearson分析肝纤维化评分与各指标相关性;运用二元Logistic回归计算NAFLDFS与NAFLD、IR的风险性。结果随着NAFLDFS值增高,年龄(Age)、体重(Weight)、体重指数(BMI)、腰围(WC)、臀围(Hip)、糖化血红蛋白(HbA1c)、颈围(NC)、FBG、PBG、Fins、收缩压(SBP)、舒张压(DBP)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)水平逐渐增高,且三组间的差异有统计学意义;而ALT、AST、PLT、ALB、高密度脂蛋白(HDL-C)随着NAFLDFS值的增高而减小。Pearson分析显示Age、NC、WC、Hip、Weight、BMI、HbA1c、FBG、PBG、PLT与NAFLDFS正相关。随着NAFLDFS值的增加,NAFLD与IR的患病风险(OR)也增加。NAFLD的患病风险由1.22(OR=1.22)增加到1.79(OR=1.79);IR的患病风险由1.13(OR=1.13)增加到1.91(OR=1.91);进一步校正性别及年龄后,NAFLD的患病风险由1.15(OR=1.15)增加到1.53(OR=1.53);IR的患病风险由1.15(OR=1.15)增加到2.02(OR=2.02)。结论 NAFLDFS与NAFLDF及IR密切相关,在临床上可将其作为简易评价NAFLD及IR的指标。 Objective To investigate the relationship of nonalcoholic fatty liver disease fibrosis score (NAFLDFS) with the risk of fatty liver disease and insulin resistance. Methods A total of 2622 subjects from Medical Examination Center of Central hospital of Xuzhou were included in the study. Blood samples were gained to measure relative indexes, alanine aminotransferase(ALT), aspartate aminotransferase(AST), platelet cotmt(PLT), serum albumin(ALB), fasting blood glucose(FBG), 2 hour postprandial blood glucose (PBG), fasting insulin (Fins) and other related biochemical index. All the blood test results were collected to calculate nonalcoholic fatty liver disease fibrosis score and insulin resistance index(HOMA2-IR). Subjects were divided into three groups according to low diagnostic threshold(- 1.455) and high diagnostic threshold(0.676) of nonalcoholic fatty liver fibrosis score. Group AI: NAFLDFS〈- 1.455, group A2: 0.676≥NAFLDFS≥- 1.455 and group A3 NAFLDFS 〉 0.676. The correlation between liver fibrosis score and each index was analyzed by Pearson analysis. We also analyzed the risk of the fatty liver and insulin resistance with NAFLDFS. Results With the increase of the NAFLDFS, Age, Weight, BMI, WC, Hip, HbAlc, NC, FBG; PBC~ Fins, SBP, DBP, TG; TC, LDL-C level were gradually increased significantly. While ALT, AST, PLT, ALB, HDL-C were decreased with the increasing the NAFLDFS. Age, NC, WC, Hip, Weight, BMI, HbAlc, FBG~ PBG and PLT were positively related to NAFLDFS according to Pearsonanalysis. Along with the increasing of NAFLDFS, the risk of NAFLD and insulin resistance also increased. Unadjusted variables non-alcoholic fatty liver risk increased from 1.22(OR= 1.22) to 1.79(OR= 1.79), risk of insulin resistance(OR=-1.13)increased froml.13 to 1.91(OR=1.91). After corrected gender and age, the risk of non-alcoholic fatty liver increased from 1.15(OR= 1.15) to 1.53(OR= 1.53); insulin resistance risk increased by 1.15(OR=l.15)to 2.02(OR=2.02). Coadusion The NAFLDFS level were closely related with non-alcoholic fatty liver and insulin resistance index, which can be used as a simple evaluation of nonalcoholic fatty liver disease and insulin resistance index in clinical.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第17期40-44,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 非酒精性脂肪肝肝纤维化评分 非酒精性脂肪肝 胰岛素抵抗 Nonalcoholic fatty liver fibrosis score Nonalcoholic fatty liver Insulin resistance
  • 相关文献

参考文献17

二级参考文献67

共引文献758

同被引文献77

  • 1黄聪武,詹海勇,李国平,郑宗茂,吴灵飞.灯盏细辛与乙型病毒性肝炎患者肝纤维化指标关系的研究[J].中国实用医药,2007,2(4):1-3. 被引量:3
  • 2中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:383
  • 3《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):283-285. 被引量:304
  • 4Adams LA, Harmsen S, St Sauver JL, et al. Non-al coholic fatty liver disease increases risk of death among patients with diabetes .. a community-based cohort study [J]. Am J Gastroenterol,2010,105(7) :1567-1573.
  • 5Angulo P, Hui JM, Marchesini G, et al. The NAFLD fi brosis score: a noninvasive system that identifies liver fibrosis inpatients with NAFLD[J]. Hepatology, 2007, 45(4) :846- 854.
  • 6Xia MF, Yan HM, He WY, et al. Standardized ultra- sound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content:An improvement method[J].Obesity(Silver Spring) ,2012,20(2) :444- 452.
  • 7Chalasani N, Younossi Z, Lavine JE, et al. The Diagno sis and Manageme-nt of Non-Alcoholic Fatty Liver Dis- ease: Practice Guideline by the American Gastroenter ological Association, American Association for the Study of Liver Diseases, and American College of Gas- troenterology[J]. Gastroenterology, 2012,142 (7) :1592- 1609.
  • 8Angulo P, Bugianesi E, Bjornsson ES, et al. Simple non- invasive systems predict long term outcomes of patients with non-alcoholic fatty liver disease[J]. Gastroenterol- ogy,2013,145(4):782 -789.
  • 9Zhou Y J, Li YY, Nie YQ, et al. Natural course of nonal coholic fatty liver disease in southern China:a prospec tire cohort study[J]. J Dig Dis,2012,13(3) :153 -160.
  • 10Hu X, Huang Y, Bao Z, et al. Prevalence and {actors as sociated with non-alcoholic fatty liver disease in shang hai work-units[J]. BMC Gastroenterol, 2012,12: 123.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部